Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 1 of 1 entries
Sorted by: Best Match Show Resources per page
Suicide genes: monitoring cells in patients with a safety switch.

Frontiers in pharmacology

Eissenberg LG, Rettig M, Dehdashti F, Piwnica-Worms D, DiPersio JF.
PMID: 25414668
Front Pharmacol. 2014 Nov 06;5:241. doi: 10.3389/fphar.2014.00241. eCollection 2014.

Clinical trials increasingly incorporate suicide genes either as direct lytic agents for tumors or as safety switches in therapies based on genetically modified cells. Suicide genes can also be used as non-invasive reporters to monitor the biological consequences of...

Cite
Eissenberg LG, Rettig M, Dehdashti F, et al. Suicide genes: monitoring cells in patients with a safety switch. Front Pharmacol. 2014;5:241doi: 10.3389/fphar.2014.00241.
Eissenberg, L. G., Rettig, M., Dehdashti, F., Piwnica-Worms, D., & DiPersio, J. F. (2014). Suicide genes: monitoring cells in patients with a safety switch. Frontiers in pharmacology, 5241. https://doi.org/10.3389/fphar.2014.00241
Eissenberg, Linda G, et al. "Suicide genes: monitoring cells in patients with a safety switch." Frontiers in pharmacology vol. 5 (2014): 241. doi: https://doi.org/10.3389/fphar.2014.00241
Eissenberg LG, Rettig M, Dehdashti F, Piwnica-Worms D, DiPersio JF. Suicide genes: monitoring cells in patients with a safety switch. Front Pharmacol. 2014 Nov 06;5:241. doi: 10.3389/fphar.2014.00241. eCollection 2014. PMID: 25414668; PMCID: PMC4222135.
Copy Download .nbib Format: NLM
Showing 1 to 1 of 1 entries